The Board dismissed this Section 2(d) opposition to registration
of the mark shown below left, for software "for providing
information to medical personnel and patients regarding the cost of
a patient's prescription medication taking into account that
patient's insurance coverage," finding that opposer had
failed to prove a likelihood of confusion with the two registered
marks shown below right, for various medical services and
publications. H. Lee Moffitt Cancer Center and Research
Institute, Inc. v. Milligram, Inc., Opposition No.
91228243 (February 11, 2018) [not precedential] (Opinion by Judge
Marc A. Bergsman).

Goods and Services: Opposer Moffitt failed to
proved that its goods and services are related to applicant's
software. Although "intuitively the 'evaluation and
testing of drug and treatment effectiveness relating to cancer and
other diseases' should have a connection to pharmacy
services," applicant's description of goods and services
does not